The NeurologyLive® Migraine Disease Spotlight page offers specific updates and coverage on the latest expert conversations and data readouts related to the treatment and management of patients with migraine disorders.
March 13th 2025
Findings from a recently published large-scale analysis highlighted the high burden of cognitive impairment among veterans with both migraine and TBI.
December 18th 2024
FDA Approves Expanded Age Indication for Nerivio Migraine Device in Pediatric Patients
November 14th 2024Nerivio, a nondrug option for acute migraine attacks and prevention of migraine with or without aura, has been FDA-approved for several years in adolescents aged 12 and older as well as adults.
The Broader Impact of Eptinezumab for Chronic Migraine Management: Fawad Khan, MD, FACNS, FAHS
Published: June 17th 2024 | Updated: June 19th 2024The director of The McCasland Family Comprehensive Headache Center talked about findings from a study that explored the effect of eptinezumab treatment in a broader chronic migraine population. [WATCH TIME: 6 minutes]
Overlooked Neurological Features Present in Long COVID: Svetlana Blitshteyn, MD, FAAN
May 13th 2024The director of Dysautonomia Clinic talked about advocating for recognition and research into neurological symptoms that have long been overlooked in patients with Long COVID. [WATCH TIME: 3 minutes]
Understanding the Impact of Data Analysis on Preventive Migraine Treatment: Jessica Ailani, MD
May 7th 2024The director of the MedStar Georgetown Headache Center discussed the importance of maintaining hope and providing understanding of patients' frustrations in their treatment journey for migraine. [WATCH TIME: 5 minutes]
Consistent Efficacy of Eptinezumab as Migraine Prevention Treatment: Jessica Ailani, MD
April 22nd 2024The director of the MedStar Georgetown Headache Center talked about an intravenous migraine treatment that could offer long-term relief for most patients who respond well to the initial dose. [WATCH TIME: 5 minutes]
Integrative and Alternative Patient-Centered Therapies in Neurology: Carolyn Bernstein, MD
April 17th 2024The assistant professor of neurology at Harvard Medical School talked about integrative therapies that may offer promising alternatives to traditional treatments for aiding neurological conditions. [WATCH TIME: 5 minutes]
Understanding Neurological Manifestations in Long COVID: Svetlana Blitshteyn, MD, FAAN
April 9th 2024The director of Dysautonomia Clinic discussed neurological manifestations of Long COVID, such as headache, cognitive complaints, and sleep problems, and how they are similar to those seen with migraine comorbidities. [WATCH TIME: 5 minutes]
Surveying the Effect of Cannabis Use for Migraine and Headache Management
April 2nd 2024Allison Verhaak, PhD, a clinical psychologist from Ayer Neuroscience Institute at Hartford Healthcare Headache Center, shared her insights on a recent study that explored cannabis use among patients with headache and migraine.
The Persistent Burden of Migraine Despite Treatment Advances: Amaal Starling, MD, FAHS, FAAN
March 20th 2024The associate professor in the department of neurology at Mayo Clinic College of Medicine talked about the significant disease burden experienced by patients with migraine even as therapeutics have advanced for the condition. [WATCH TIME: 8 minutes]
Researching Posttraumatic Headache With Cranial Neuralgias: Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
July 27th 2021The assistant professor of neurology at Harvard Medical School discussed the motivation behind uncovering more about painful cranial neuralgias and their association with posttraumatic headache.